These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1530225)
1. [Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids]. Juchet H; Arlet P; Ollier S; Montané de la Roque P; Le Tallec Y Ann Med Interne (Paris); 1992; 143(2):85-8. PubMed ID: 1530225 [TBL] [Abstract][Full Text] [Related]
2. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270 [TBL] [Abstract][Full Text] [Related]
3. [Value of dapsone in the treatment of Horton's disease and rhizomelic pseudopolyarthritis]. Doury P; Pattin S; Eulry F; Maurel C; Masson C; Tabaraud F Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):277-80. PubMed ID: 6879094 [TBL] [Abstract][Full Text] [Related]
5. [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. Doury P; Fabresse FX; Pattin S; Eulry F; Celton H; Larroque P Ann Med Interne (Paris); 1984; 135(1):31-5. PubMed ID: 6703568 [TBL] [Abstract][Full Text] [Related]
6. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275 [TBL] [Abstract][Full Text] [Related]
7. [Results of a regional survey on the treatment of rhizomelic pseudopolyarthritis and temporal arteritis. Apropos of 242 cases treated by various modalities with synthetic antimalarials, corticoids and non-steroidal anti-inflammatory agents]. David-Chaussé J; Dehais J; Leman A Rev Rhum Mal Osteoartic; 1983; 50(8-9):563-71. PubMed ID: 6635510 [TBL] [Abstract][Full Text] [Related]
9. [Horton's disease and rhizomelic pseudopolyarthritis. Developmental data apropos of 95 cases]. Piton JL; Zagala A; Rebuffet JL; Reynes O; Reynes JF; Souteyrand P; Phelip X Rev Rhum Mal Osteoartic; 1987 Jan; 54(1):7-13. PubMed ID: 3563372 [TBL] [Abstract][Full Text] [Related]
10. [Principles of acute treatment of Horton's disease. Role of high-dose corticosteroid therapy]. Barrier JH; Chevalet P; Ponge T Ann Med Interne (Paris); 1998 Nov; 149(7):448-53. PubMed ID: 9921399 [TBL] [Abstract][Full Text] [Related]
11. [The bane of giant cell arteritis from an ophthalmological viewpoint]. Meli B; Landau K; Gloor BP Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521 [TBL] [Abstract][Full Text] [Related]
12. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. Lundberg I; Hedfors E J Rheumatol; 1990 Oct; 17(10):1340-5. PubMed ID: 2254893 [TBL] [Abstract][Full Text] [Related]
13. Polymyalgia rheumatica and giant cell arteritis. Unwin B; Williams CM; Gilliland W Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894 [TBL] [Abstract][Full Text] [Related]
14. [Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy]. Hatz HJ; Helmke K Z Rheumatol; 1992; 51(5):213-21. PubMed ID: 1476006 [TBL] [Abstract][Full Text] [Related]
15. [Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients]. Sailler L; Carreiro M; Ollier S; Juchet H; Delobel P; Ferrand D; Klinger M; Arlet P Rev Med Interne; 2001 Nov; 22(11):1032-8. PubMed ID: 11817115 [TBL] [Abstract][Full Text] [Related]
16. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens. Di Munno O; Imbimbo B; Mazzantini M; Milani S; Occhipinti G; Pasero G J Rheumatol; 1995 Aug; 22(8):1492-8. PubMed ID: 7473472 [TBL] [Abstract][Full Text] [Related]